Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 21.34B 3.19B 2.84B 2.64B 2.4B 4.53B 303B 4.61B 31.73B 12.41B 158B 11.97B 11.72B 504B P/E 2026 *
14.4x
P/E 2027 * 12.5x
Enterprise Value 18B 2.69B 2.4B 2.22B 2.03B 3.82B 256B 3.89B 26.76B 10.47B 133B 10.09B 9.88B 425B EV / Sales 2026 *
0.61x
EV / Sales 2027 * 0.54x
Free-Float
34.77%
Yield 2026 *
5.03%
Yield 2027 * 5.57%
1 day-1.32%
1 week+2.97%
Current month+2.97%
1 month+2.68%
3 months-4.78%
6 months+9.85%
Current year+6.36%
1 week 18.2
Extreme 18.2
19.48
1 month 17.32
Extreme 17.32
19.48
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 16/07/2013
Director/Board Member 63 08/08/2016
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.32%+2.97%+11.48%-22.79% 3.23B
+1.62%+6.79%-39.03%-1.85% 15.09B
+12.21%-1.10%+7.21%-24.56% 7.24B
+2.45%+3.90%-13.52%-1.46% 6.12B
+3.35%+4.32%-12.26%+4.67% 6.01B
+2.96%+4.96%-50.25%-39.96% 5.92B
+1.85%+11.11%+7.42%-7.31% 4.6B
+0.67%+13.05%-34.43%-7.24% 3.33B
+3.34%+1.80%-23.18%-6.79% 3.11B
+0.75%-4.64%-28.13%-38.30% 3B
Average +2.79%+1.99%-17.47%-14.56% 5.77B
Weighted average by Cap. +3.20%+2.41%-20.65%-11.98%

Financials

2026 *2027 *
Net sales 29.54B 4.42B 3.94B 3.65B 3.33B 6.27B 420B 6.38B 43.92B 17.18B 219B 16.56B 16.22B 698B 32.52B 4.86B 4.33B 4.02B 3.66B 6.9B 462B 7.02B 48.35B 18.92B 241B 18.24B 17.85B 768B
Net income 1.49B 222M 198M 184M 167M 315M 21.11B 321M 2.21B 864M 11B 833M 816M 35.1B 1.71B 256M 228M 211M 193M 363M 24.31B 370M 2.54B 995M 12.67B 960M 939M 40.42B
Net Debt -3.34B -499M -445M -413M -376M -708M -47.45B -721M -4.97B -1.94B -24.73B -1.87B -1.83B -78.89B -3.76B -562M -501M -465M -423M -798M -53.42B -812M -5.59B -2.19B -27.84B -2.11B -2.06B -88.82B
Projected Income Statement - Annual - DaShenLin Pharmaceutical Group Co., Ltd.
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
15/10/26 CN¥18.74 -1.32% 13,992,116
14/10/26 CN¥18.99 +0.26% 14,142,196
13/10/26 CN¥18.94 -1.35% 14,478,966
12/10/26 CN¥19.20 +2.35% 16,594,205
09/10/26 CN¥18.76 +2.18% 13,582,012
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - DaShenLin Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.74CNY
Average target price
23.75CNY
Spread / Average Target
+26.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DaShenLin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 603233 Stock